Home>Topics>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR GSK

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. UPDATE 1-First GSK Ebola vaccine shipment due to arrive in Liberia

      Headlines

      Fri, 23 Jan 2015

      * Drugs, vaccines still needed for this and future outbreaks (Adds comment from director of Wellcome Trust, bullets)

    2. First GSK Ebola vaccine shipment due to arrive in Liberia

      Headlines

      Fri, 23 Jan 2015

      LONDON, Jan 23 (Reuters) - The first batch of GlaxoSmithKline's experimental Ebola vaccine has been shipped to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said.

    3. BRIEF-Ablynx says successfully opposes Domantis patent appeal case

      Headlines

      Thu, 22 Jan 2015

      * Ablynx successfully opposes patent appeal case by Domantis ( GSK )

    4. MSF slams expensive vaccines, urges GSK and Pfizer to cut prices

      Headlines

      Tue, 20 Jan 2015

      LONDON, Jan 20 (Reuters) - the international charity Medecins Sans Frontieres urged drugmakers GlaxoSmithKline and Pfizer on Tuesday to slash the price of their pneumococcal vaccines to $5 per child in poor countries.

    5. GSK's nicotine patches and gum feel the heat from e-cigarettes

      Headlines

      Fri, 16 Jan 2015

      LONDON, Jan 16 (Reuters) - GlaxoSmithKline is feeling the heat from the rapid growth in electronic cigarettes, with enthusiasm for the nicotine delivery devices dampening sales of the British drugmaker's patches and gum, its chief executive said.

    6. Isis’ Deal with J&J Underlines Broad Potential of its Antisense Technology; Increasing FVE

      Commentary

      Mon, 5 Jan 2015

      tract. The deal will add to its already long list of pipeline opportunities and strong commercialization partners (Sanofi, GSK , Roche, AstraZeneca, and Biogen). We are maintaining our no moat, positive trend rating as most of its pipeline is still

    7. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

      Video Reports

      Fri, 2 Jan 2015

      Coffina: I also want to just talk about [TICKER: GSK ] GlaxoSmithKline ( GSK ). This company, I think, was our top-ranked firm ..... the other end of the spectrum, Pfizer and [TICKER: GSK ] GlaxoSmithKline didn't score as well. In both

      GSK found at 2:52, 4:02

      line looks very, very challenging. Coffina: I also want to just talk about [TICKER: GSK ] GlaxoSmithKline ( GSK ). This company, I think, was our top-ranked firm last year. It's toward the bottom this year. So obviously, some things didn't go
      the next five years. On the other end of the spectrum, Pfizer and [TICKER: GSK ] GlaxoSmithKline didn't score as well. In both cases, the companies are facing patent losses, relatively weak in-line product sales, and not enough
    8. Hold,Add or Sell EHI and JPI

      Commentary

      Wed, 31 Dec 2014

      In my portfolio,i have a 10% + loss in EHI,JPI ,PCI and GSK .All 4 are in Roth. I plan to continue adding to PCI and GSK . But i have no clarity on EHI and JPI. Appreciate your feedback.

    9. NewLink, GSK get U.S. funding for faster development of Ebola vaccines

      Headlines

      Tue, 23 Dec 2014

      Dec 23 (Reuters) - The U.S. Department of Health and Human Services (HHS) awarded contracts worth a total of about $43 million to NewLink Genetics Corp and GlaxoSmithKline Plc for faster development of two Ebola vaccines.

    10. GSK Ebola vaccine trial seen moving to wider phase in February

      Headlines

      Fri, 19 Dec 2014

      GENEVA, Dec 19 (Reuters) - Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national...

    « Prev12345Next »
    Content Partners